Cours PharmaCyte Biotech, Inc. Other OTC
Actions
PMCB
US71715X1046
Produits pharmaceutiques
CA 2022 | - | CA 2023 | - | Capitalisation | 50,93 M 46,43 M |
---|---|---|---|---|---|
Résultat net 2022 | -4 M -3,65 M | Résultat net 2023 | -4 M -3,65 M | VE / CA 2022 | - |
Trésorerie nette 2022 | 85,4 M 77,85 M | Trésorerie nette 2023 | 68,04 M 62,02 M | VE / CA 2023 | - |
PER 2022 |
-8,53
x | PER 2023 |
-13,2
x | Employés | - |
Rendement 2022 * |
-
| Rendement 2023 |
-
| Flottant | 35,95% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Joshua Silverman
CEO | Chief Executive Officer | 53 | 15/08/22 |
Carlos Trujillo
DFI | Director of Finance/CFO | 66 | 01/01/15 |
José Iglesias
CTO | Chief Tech/Sci/R&D Officer | - | 10/08/20 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Robert Weinstein
BRD | Director/Board Member | 64 | 14/11/22 |
Joshua Silverman
CEO | Chief Executive Officer | 53 | 15/08/22 |
Wayne Walker
BRD | Director/Board Member | 65 | 28/12/22 |
Varia. 1 janv. | Capi. | |
---|---|---|
+25,83% | 661 Md | |
+27,00% | 566 Md | |
-6,76% | 352 Md | |
+20,34% | 332 Md | |
+3,00% | 283 Md | |
+13,09% | 231 Md | |
+5,46% | 200 Md | |
-9,61% | 195 Md | |
-6,26% | 145 Md |